Benzonatate Capsule
Product Images NDC 51655-762

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 51655-762). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 762 20 Master Bottle Label Approval Rev A 07 21)

Label for Benzonatate Capsules USP 200 mg. The label indicates a package containing 20 oral capsules. It includes storage instructions at 20°-25°C (68°-77°F), safety warnings to keep out of reach of children, and to store in the original container protected from light. The label also references Northwind Pharmaceuticals as the repackager and lists an NDC of 51655-762-20.*

FDA Label Image

Structure Formula (Structure Formula)

Chemical structure of the active ingredient Benzonatate, showing its molecular formula as C30H53NO11 with depicted functional groups and bonding arrangement.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.